23 Feb Gamida Cell
Posted at 19:05h
in
Abbey Jenkins, President and CEO
Oct. 11 | 4:45pm | Aseptic Technologies Ballroom
Boston, MA
(NASDAQ: GMDA)
Gamida Cell is a cell therapy pioneer working to turn cells into powerful therapeutics. Our proprietary nicotinamide (NAM) technology leverages the properties of NAM to enhance and expand cells, creating allogeneic cell therapy products and candidates that are potentially curative for patients with hematologic malignancies. We work with a sense of urgency and deeply held responsibility to address the clear need for new treatment options. And we do all that we can to ensure access to our therapies for patients who can benefit from them. Our first commercial product was approved by the U.S. FDA in April 2023.
